PEGASYS

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug PEGASYS contains one active pharmaceutical ingredient (API):

1 Peginterferon alpha-2a
UNII Q46947FE7K - PEGINTERFERON ALFA-2A

Peginterferon alpha-2a is a pegylated interferon alfa-2a that possesses the in vitro antiviral and antiproliferative activities that are characteristic of interferon alfa-2a. Peginterferon alpha-2a is indicated for the treatment of hepatitis B and C.

Read about Peginterferon alpha-2a

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PEGASYS Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AB11 Peginterferon alfa-2a L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11037X, 11416W, 6439X, 6449K, 9515T, 9516W
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 529204002151210
Country: CA Health Products and Food Branch Identifier(s): 02248077
Country: EE Ravimiamet Identifier(s): 1110340, 1110351, 1110362, 1110373, 1110384, 1110395, 1110407, 1110418, 1214828, 1214839, 1609523, 1609534, 1609545, 1609556, 1609567, 1609578, 1646197, 1820281, 1843905, 1847853, 1888274
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 02221006, 02221008, 102221017
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 008767, 008782
Country: FR Base de données publique des médicaments Identifier(s): 64347476, 67042907, 67134227
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 226859, 43381, 43384
Country: HK Department of Health Drug Office Identifier(s): 51529, 51530
Country: IE Health Products Regulatory Authority Identifier(s): 88365, 88402
Country: JP 医薬品医療機器総合機構 Identifier(s): 6399419A1022, 6399419A2029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1004853, 1011191, 1011192, 1011193, 1011194, 1011195, 1030176, 1030177, 1030178, 1030179, 1064244, 1064245, 1064246, 1064247, 1064248, 1064249, 1071714
Country: NL Z-Index G-Standaard Identifier(s): 14753588, 14753596
Country: NL Z-Index G-Standaard, PRK Identifier(s): 105740, 106364, 106372, 63533, 63541
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10133
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100112598, 100112606, 100112612, 100112629, 100295825
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W68070001, W68070002, W68070003
Country: SG Health Sciences Authority Identifier(s): 12313P, 12314P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 4773014H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699514950004, 8699514950257, 8699514950264, 8699514950271
Country: US FDA, National Drug Code Identifier(s): 0004-0350, 0004-0357
Country: ZA Health Products Regulatory Authority Identifier(s): 38/26/0180

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.